bioRxivMolecular BiologyPreprint
Nuclear GAPDH cascade mediates stress-dependent pathological cardiac growth
Shun NakamuraiD, Manling ZhangiD, Genri NumataiD, Taro KariyaiD, Hideyuki Sasaki, Masayuki SasakiiD, Adriana RamosiD, Eisuke Amiya, Masaru Hatano, Masahiko Ando, Yoichi Yasunaga, Masaki IwakiriiD, Norimichi KoitabashiiD, Guangshuo Zhu, Tsuyoshi Tsujimura, Dong I. LeeiD, Carlos A. TristaniD, Neelam ShahaniiD, Yukihiro Tsuchiya, Hanna Jaaro-PelediD, Tetsuo SasanoiD, Barbara Stauch SlusheriD, David A. KassiD, Tetsuo Ushiku, Minoru Ono, , Eiki TakimotoiD
- Citations
- 4
Abstract
Here we report that stress-induced nuclear translocation of GAPDH mediates heart hypertrophy via Brahma-Related-Gene-1 (BRG1)-associated chromatin remodelling. In response to pressure overload elicited by transverse aortic constriction, we observed nuclear translocation of GAPDH in the mouse heart. We also demonstrated a robust nuclear localization of GAPDH in cardiomyocytes from patients with dilated hypertrophic cardiomyopathy, whereas negligible GAPDH in the nucleus in control subjects. This is the first demonstration of disease-associated nuclear GAPDH directly in living patients. Using immunohistochemical methods and a pharmacological way that selectively blocks GAPDH nuclear translocation (RR compound), we proved the causal involvement of GAPDH cysteine-150 modification in this translocation in Gq-induced cell model for heart hypertrophy. Accordingly, both pharmacological and genetic interventions proved that the same mechanism played a causal role for heart hypertrophy and dysfunction in vivo. We discovered that, upon nuclear translocation, GAPDH augmented the protein interaction of BRG1 and histone deacetylase 2 (HDAC2), which further facilitated the Myh7/Myh6 isoform ratio from the mature to immature status, an essential mechanism for heart hypertrophy. Beyond medical implications, we provide a novel mechanism of stress-induced reversion of a cellular phenotype from adult to fetal state, which is mediated by a "moonlighting" function of GAPDH.
- organism: mouse
- organism: human
- assay: protein structure
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deletion of Setd7 protects against cardiac hypertrophy via inhibiting lipid oxidation
Haibi Su, Jinghuan Wang, … Xinhua Liu·bioRxiv·Jul 29, 2024
- ZDHHC14-Mediated Palmitoylation of TBK1 Promotes Pathological Cardiac Hypertrophy via Type I Interferon Signaling Activation
Wei Zhao, Ying Yang, … Rui‐Xia Xu·bioRxiv·Jul 26, 2026
- YAP dysregulation triggers hypertrophy by CCN2 secretion and TGFβ uptake in human pluripotent stem cell-derived cardiomyocytes
Orlando Chirikian, Mohamed A. Faynus, … Beth L. Pruitt·bioRxiv·Jun 3, 2024
- CD163+/Dab2+ Macrophages Alleviate Cardiac Hypertrophy via Nrg2/ErbB4-Mediated Mitochondrial Reprogramming
Qi Zhu, Shuilin Liao, … Dong Ming·bioRxiv·May 22, 2025
- Cardiac Gq receptors and calcineurin activation are not required for the hypertrophic response to mechanical left ventricular pressure overload
Ze‐Yan Yu, Hutao Gong, … Michael Patrick Feneley·Frontiers in Cell and Developmental BiologyPeer-reviewed·Feb 15, 2021
- Differential activation of P-TEFb complexes in the development of cardiomyocyte hypertrophy following activation of distinct GPCRs
Ryan Martin, Ya‐Lin Sun, … Jason C. Tanny·Molecular and Cellular BiologyPeer-reviewed·Apr 22, 2020